Angiodynamics (ANGO) Receivables - Other (2012)
Angiodynamics' (ANGO) quarterly Receivables - Other came in at $2.5 million in Q4 2012, little changed quarter-over-quarter from $2.5 million in Q3 2012.
Analysis
Angiodynamics (ANGO) Receivables - Other (2012) Analysis & Trends
Angiodynamics (ANGO) has reported Receivables - Other for 1 consecutive years, with $2.5 million the latest figure, recorded in Q4 2012.
- For the quarter ending Q4 2012, Receivables - Other changed N/A year-over-year to $2.5 million; the trailing twelve-month figure through Nov 2012 stood at $2.5 million (changed N/A YoY), and the FY2012 full-year result was $2.5 million, changed N/A from the prior year.
- Receivables - Other was little changed at $2.5 million in Q4 2012 per ANGO's latest filing, from $2.5 million in the prior quarter.
- Across five years, Receivables - Other topped out at $2.5 million in Q2 2012 and bottomed at $2.5 million in Q2 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.69 Bn | 175.09 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.23 Bn | 122.02 Bn | 1.96 Bn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn |
| 4 | Stryker | 103.91 Bn | 100.43 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.54 Bn | 63.00 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.96 Bn | 31.51 Bn | 1.68 Bn |
| 8 | Dexcom | 32.02 Bn | 30.07 Bn | 830.00 Mn |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Angiodynamics | 626.21 Mn | 572.35 Mn | 46.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Nov 30, 2012 | 2.50 Mn |
| Aug 31, 2012 | 2.50 Mn |
| May 31, 2012 | 2.50 Mn |